Danaher Corp
DHR189.900USD
-0.615-0.32%
Fechamento 05/30, 16:00（ET）Cotações atrasadas em 15 min
135.89BValor de mercado
34.85P/L TTM
Mais detalhes de Danaher Corp Empresa
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
Informações da empresa
Código da empresaDHR
Nome da EmpresaDanaher Corp
Data de listagemDec 10, 1969
Fundado em1986
CEOMr. Rainer M. Blair
Número de funcionários61000
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 10
Endereço2200 Pennsylvania Ave NW Ste 800W
CidadeWASHINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal20037-1701
Telefone12028280850
Sitehttps://www.danaher.com/
Código da empresaDHR
Data de listagemDec 10, 1969
Fundado em1986
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
-2.87%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
34.93M
-0.58%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
85.52K
+0.68%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
46.53K
-37.14%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
38.82K
+1.51%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President, General Counsel
Senior Vice President, General Counsel
22.53K
+445.78%
Mr. Daniel A. Raskas, J.D.
Mr. Daniel A. Raskas, J.D.
Senior Vice President - Corporate Development
Senior Vice President - Corporate Development
16.02K
-22.69%
Dr. Elias A. Zerhouni, M.D.
Dr. Elias A. Zerhouni, M.D.
Independent Director
Independent Director
13.47K
+4.47%
Prof. Raymond C. Stevens, Ph.D.
Prof. Raymond C. Stevens, Ph.D.
Independent Director
Independent Director
6.96K
+9.04%
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Dr. Jose-Carlos Gutierrez-Ramos, Ph.D.
Senior Vice President, Chief Science Officer
Senior Vice President, Chief Science Officer
5.71K
+90.72%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Steven M. Rales
Mr. Steven M. Rales
Chairman of the Board
Chairman of the Board
42.24M
-2.87%
Mr. Mitchell P. Rales
Mr. Mitchell P. Rales
Director
Director
34.93M
-0.58%
Mr. Alan G. Spoon, J.D.
Mr. Alan G. Spoon, J.D.
Independent Director
Independent Director
85.52K
+0.68%
Mr. Rainer M. Blair
Mr. Rainer M. Blair
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
46.53K
-37.14%
Mr. John T. Schwieters
Mr. John T. Schwieters
Independent Director
Independent Director
38.82K
+1.51%
Mr. Brian W. Ellis
Mr. Brian W. Ellis
Senior Vice President, General Counsel
Senior Vice President, General Counsel
22.53K
+445.78%
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
All Other
11.14B
46.67%
United States
9.93B
41.58%
China
2.81B
11.75%
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: sex, 16 de mai
Tempo de atualização: sex, 16 de mai
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
8.34%
Rales (Steven M)
5.90%
Rales (Mitchell P)
4.88%
BlackRock Institutional Trust Company, N.A.
4.14%
State Street Global Advisors (US)
3.84%
Other
72.89%
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
8.34%
Rales (Steven M)
5.90%
Rales (Mitchell P)
4.88%
BlackRock Institutional Trust Company, N.A.
4.14%
State Street Global Advisors (US)
3.84%
Other
72.89%
Tipo
Acionista
Proporção
Investment Advisor
36.18%
Investment Advisor/Hedge Fund
33.57%
Individual Investor
10.85%
Hedge Fund
4.20%
Research Firm
2.55%
Pension Fund
2.10%
Bank and Trust
2.04%
Sovereign Wealth Fund
1.38%
Family Office
0.39%
Other
6.74%
Participação acionária institucional
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
3867
665.42M
92.97%
-12.84M
2024Q4
3912
666.25M
93.21%
-12.81M
2024Q3
3803
666.72M
92.18%
-22.04M
2024Q2
3748
676.83M
91.56%
-20.35M
2024Q1
3757
684.50M
92.62%
-9.01M
2023Q4
3766
684.46M
92.71%
-1.58M
2023Q3
3680
678.81M
92.01%
-4.67M
2023Q2
3635
673.50M
91.35%
-658.33K
2023Q1
3602
668.24M
91.66%
-2.23M
2022Q4
3575
666.43M
91.51%
-6.25M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
59.47M
8.31%
+332.85K
+0.56%
Dec 31, 2024
Rales (Steven M)
43.49M
6.08%
+366.00
+0.00%
Mar 01, 2025
Rales (Mitchell P)
34.93M
4.88%
-202.39K
-0.58%
Mar 01, 2025
BlackRock Institutional Trust Company, N.A.
29.32M
4.1%
+350.54K
+1.21%
Dec 31, 2024
State Street Global Advisors (US)
27.38M
3.83%
-95.41K
-0.35%
Dec 31, 2024
T. Rowe Price Associates, Inc.
18.05M
2.52%
-1.50M
-7.69%
Dec 31, 2024
Wellington Management Company, LLP
21.32M
2.98%
-1.99M
-8.53%
Dec 31, 2024
Capital International Investors
17.66M
2.47%
-169.50K
-0.95%
Dec 31, 2024
Geode Capital Management, L.L.C.
13.36M
1.87%
+315.45K
+2.42%
Dec 31, 2024
Fidelity Management & Research Company LLC
18.77M
2.62%
-3.07M
-14.05%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: ter, 6 de mai
Tempo de atualização: ter, 6 de mai
Nome
Proporção
Parnassus Core Select ETF
7.94%
Macquarie Focused Large Growth ETF
7.87%
Simplify Health Care ETF
5.95%
Monarch Blue Chips Core ETF
4.27%
VanEck Morningstar Wide Moat Value ETF
4.08%
Bancreek U.S. Large Cap ETF
3.03%
God Bless America ETF
2.91%
Goldman Sachs Future Health Care Equity ETF
2.48%
Proshares Ultra Health Care
2.46%
Health Care Select Sector SPDR Fund
2.42%
Ver Mais
Parnassus Core Select ETF
Proporção7.94%
Macquarie Focused Large Growth ETF
Proporção7.87%
Simplify Health Care ETF
Proporção5.95%
Monarch Blue Chips Core ETF
Proporção4.27%
VanEck Morningstar Wide Moat Value ETF
Proporção4.08%
Bancreek U.S. Large Cap ETF
Proporção3.03%
God Bless America ETF
Proporção2.91%
Goldman Sachs Future Health Care Equity ETF
Proporção2.48%
Proshares Ultra Health Care
Proporção2.46%
Health Care Select Sector SPDR Fund
Proporção2.42%
Dividendo
Um total de
3.76B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Feb 20, 2025
DHR.NB Interim Cash Dividend of gross USD 0.32 paid on Apr 25, 2025 going ex on Mar 28, 2025
Mar 28, 2025
Apr 25, 2025
Mar 28, 2025
Dec 10, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jan 31, 2025 going ex on Dec 27, 2024
Dec 27, 2024
Jan 31, 2025
Dec 27, 2024
Sep 10, 2024
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 25, 2024 going ex on Sep 27, 2024
Sep 27, 2024
Oct 25, 2024
Sep 27, 2024
May 07, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 26, 2024 going ex on Jun 28, 2024
Jun 28, 2024
Jul 26, 2024
Jun 28, 2024
Feb 21, 2024
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 26, 2024 going ex on Mar 27, 2024
Mar 28, 2024
Apr 26, 2024
Mar 27, 2024
Dec 05, 2023
DHR.NB Interim Cash Dividend of gross USD 0.24 paid on Jan 26, 2024 going ex on Dec 28, 2023
Dec 29, 2023
Jan 26, 2024
Dec 28, 2023
Sep 13, 2023
DHR.NB Final Cash Dividend of gross USD 0.27 paid on Oct 27, 2023 going ex on Oct 11, 2023
Oct 12, 2023
Oct 27, 2023
Oct 11, 2023
May 09, 2023
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Jul 28, 2023 going ex on Jun 29, 2023
Jun 30, 2023
Jul 28, 2023
Jun 29, 2023
Feb 22, 2023
DHR.NB Interim Cash Dividend of gross USD 0.27 paid on Apr 28, 2023 going ex on Mar 30, 2023
Mar 31, 2023
Apr 28, 2023
Mar 30, 2023
Dec 06, 2022
DHR.NB Interim Cash Dividend of gross USD 0.25 paid on Jan 27, 2023 going ex on Dec 29, 2022
Dec 30, 2022
Jan 27, 2023
Dec 29, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
